Introduction
Systemic lupus erythematosus (SLE) is a chronic autoimmune condition with multiorgan involvement and a high risk of cardiac complications; however, the acute cardiac manifestations of SLE, including pericarditis, myocarditis, endocarditis, and valvular insufficiency, are frequently asymptomatic. 1, 2 Transthoracic echocardiography is useful for assessing structural and functional abnormalities resulting from acute manifestations of SLE. 3 It has additional advantages of being noninvasive and free of radiation, which are especially desirable in the care of children and adolescents. In the limited studies of cardiac involvement in childhood-onset SLE, the vast majority of acute cardiac manifestations occur within six months of SLE diagnosis. 4 Therefore, peri-diagnostic echocardiography has the ability to identify cardiac involvement early in the disease course and may affect treatment choice, duration, and future monitoring. There are no data on current utilization patterns of echocardiography in youth with SLE, nor is there consensus on the appropriate use of echocardiography for the evaluation of cardiac involvement at SLE diagnosis. In addition, just as routine screening echocardiography in asymptomatic adults with SLE remains controversial, [5] [6] [7] [8] it is not known whether screening echocardiography in patients with childhood-onset disease is warranted. Compared to adult-onset SLE, childhood-onset disease confers a greater potential for cumulative tissue damage, 9 and thus efforts directed toward early detection and treatment of major organ involvement are of particular importance. Assessment of current diagnostic imaging practices and exploration of the potential incremental diagnostic benefit of imaging are necessary first steps toward developing appropriate imaging guidelines.
The objectives of this study are to: (1) estimate the prevalence of acute cardiac manifestations of childhood-onset SLE using a population-based approach, (2) identify factors associated with use of echocardiography during the peri-diagnostic period in youth with SLE, and (3) assess the potential impact of variability in echocardiography use on subsequent rates of cardiac disease detection. We hypothesized that there is high prevalence of acute cardiac manifestations following SLE diagnosis in youth, and geographic areas with greater utilization of echocardiograms will have incrementally higher detection rates of cardiac disease.
Methods

Study design
A retrospective population-based cohort study was conducted.
Data source and participants
Using the Clinformatics Õ DataMart (OptumInsight, Eden Prairie, MN) de-identified United States (US) administrative claims data from 2000 through 2013, we identified youth ages 5-24 years inclusive with an incident diagnosis of SLE. OptumInsight data are derived from a national commercial health insurance and Medicare Advantage (C and D) database that includes approximately 20% of US residents. It contains de-identified patient and encounter-level data, including demographics, medical diagnoses specified by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9 CM) codes, procedure codes, prescription drug claims, and provider specialty. An exemption for this study was approved by the institutional review board at the Children's Hospital of Philadelphia (IRB #17-013682).
Youth with SLE were defined as individuals having at least three hospital or physician visit claims with an ICD-9 diagnosis code for SLE (710.0), each recorded at least 30 days apart. This algorithm has been validated in adults and published in children. 10, 11 As previously described, incident cases were defined as those who also had at least one year of claims data with no SLE codes in any position preceding the first primary or secondary SLE diagnosis code. 12 The date of SLE diagnosis was assigned as the first physician visit with a diagnosis code for SLE or the admission date of the first hospitalization with an SLE code, whichever came first. Individuals with preexisting ICD-9 codes for congenital heart disease, bacterial endocarditis or rheumatic fever were excluded from the analysis.
Study measures Acute cardiac manifestations
Acute cardiac manifestations were defined as a composite outcome of at least one ICD-9 diagnosis code for pericarditis (423.1, 423.9x and 420.xx), 13, 14 myocarditis (422.9x, 429.0), endocarditis (424.91), or valvular insufficiency (424.0-424.3, excluding rheumatic heart disease (394.1) and bacterial endocarditis (421.0-421.9)). 15 As disease manifestations can precede the recognition of SLE by months to years, we included cardiac diagnoses occurring within 12 months preceding the first SLE code until the end of enrollment.
Utilization of noninvasive diagnostic imaging
For assessment of echocardiogram utilization, the outcome was the presence of an ICD-9 procedure code 88.72 or Current Procedural Terminology billing code for transthoracic echocardiography within the baseline period, 16 defined as 12 months prior to and up to six months after the index date. To determine whether echocardiogram use reflected overall utilization of cardiac diagnostic tests, billing codes for 12-lead electrocardiography (ECG) during the baseline period were included as a secondary outcome.
Acute cardiac manifestations identified following echocardiography
In youth who underwent echocardiography during the baseline period, the primary outcome measure was the percentage of youth with their first acute cardiac manifestation occurring on or after the date of initial echocardiography. The main exposures of interest were: (1) regional echocardiogram utilization and (2) the presence of cardiovascular signs and symptoms, defined by the presence of ICD-9 diagnosis codes pertaining to the categories of chest pain, dyspnea, murmur or other abnormal heart sounds, tachycardia, and shock.
Covariates of interest
Covariates of interest included the following: demographic characteristics (age at diagnosis, calendar year, sex, race/ethnicity, geographic region, household income); hospitalization within 30 days of the first SLE code as a proxy for disease severity; disease characteristics (lupus nephritis, major central nervous system (CNS) involvement as defined by seizure or stroke, any psychiatric disorder, hypertension, venous thromboembolism or antiphospholipid antibody syndrome (APS)); prescription claims for glucocorticoids, immunosuppressants, and anticoagulants. Baseline covariates were assessed 12 months prior to the index date until the date of echocardiogram or six months after the index date.
We categorized geographic regions using the US Census Bureau groupings into nine census divisions. 17 OptumAnalytics derives household education level from census data, while race and ethnicity are derived from a combination of public records, self-report, and proprietary tables. Age was grouped into two categories, 5-17 and 18-24 years, to examine potential differences in utilization between the pediatric population and transition-age young adults. SLE nephritis was identified using a previously validated algorithm. 10, 11 Major CNS disease was defined by at least one ICD-9 code for seizure or cerebrovascular disease, [18] [19] [20] and psychiatric disorders were defined as previously described, 21 excluding substance abuse codes. Hypertension was identified using a coding algorithm validated in adults. 22 ICD-9 codes for APS (289.8x) were combined with validated codes for venous thromboembolism to identify hypercoagulable states. 23, 24 Provider subspecialty was determined using OptumAnalytics provider category codes.
Statistical analysis
Demographic factors and clinical factors were described using standard statistics such as mean and standard deviation or median and interquartile range (IQR) for continuous variables, and count and frequency for categorical variables.
Prevalence of acute cardiac disease
We calculated the proportion of youth with SLE who had diagnosis codes for acute cardiac manifestations and the median time from the first SLE code to the first cardiac diagnosis code.
Factors associated with cardiac diagnostic test utilization
The Cuzick's Wilcoxon rank-sum test of trend was used to assess changes in echocardiogram use by calendar year. To identify factors independently associated with use of echocardiography at baseline, we performed multiple logistic regression with forward selection (p value for entry 0.2). Covariates a priori determined to be of clinical significance (including age, race, household education level, and hypertension) were forced into the model and retained if any coefficient changed by more than 10%. Goodness of fit was assessed using the Pearson chi-square statistic. In a sensitivity analysis, we excluded youth with any acute cardiac manifestation codes preceding echocardiogram from the multivariable regression analysis of echocardiogram use to eliminate follow-up studies for prevalent cardiac disease. For comparison with other noninvasive cardiac testing, we used the same selection methods to perform a separate multivariable logistic regression analysis with baseline ECG as the dependent variable. To assess potential differences in referral patterns by provider specialty, we performed a subgroup analysis among youth seen by a rheumatologist during the baseline period to compare echocardiogram use in youth seen by pediatric versus adult rheumatologists.
Association between echocardiography use and incident cardiac diagnoses
We calculated the proportion of youth with SLE within each census division who underwent echocardiography during the baseline period to determine observed regional utilization. Owing to the small sample size from the East South Central division, East and West South Central divisions were combined into one South Central region for the analysis. To adjust for patient characteristics, we estimated a separate logistic regression model using all baseline covariates in Table 1 to predict the probability of echocardiogram, and averaged these probabilities across individuals within each census division. For each census division, the ratio of observed echocardiogram use over the mean predicted probability was taken as the utilization probability index. Census divisions with utilization indices greater than 1.0 were thus considered high utilizers, because observed use exceeded expected use given the patient characteristics of the region. We estimated the association between regional utilization probability index and the percentage of echocardiograms followed by an incident cardiac diagnosis using Spearman's rank correlation coefficient. Similarly, we estimated the correlation between preceding cardiovascular sign or symptom codes and incident cardiac diagnoses following echocardiography.
We performed two sensitivity analyses for the association between utilization indices and cardiac diagnoses. To investigate the impact of a more stringent SLE case definition, we limited the cohort to youth with a prescription claim for antimalarial medications. Secondly, we excluded valvular insufficiency to assess the validity of a composite outcome including both myopericardial and valvular codes. All data analyses were performed using STATA 14.2 (STATA Corp, College Station, TX) statistical software.
Results
We identified a total of 699 youth with new-onset SLE. The average continuous enrollment was 5.6 years, and average follow-up time was 3.6 years from 12 months before SLE diagnosis until the end of enrollment. Demographic and baseline disease characteristics are shown in Table 1 . During the baseline period, 17% of the cohort had a diagnosis code for renal disease, 8% had a code for CNS disease, 20% had a psychiatric diagnosis, and 5% had a diagnosis of venous thromboembolism and/or APS. By the time of echocardiogram or six months after SLE diagnosis, 539 youth (77%) saw a rheumatologist, 18% saw a nephrologist, and 34% saw a cardiologist. During enrollment, the majority of youth with SLE had prescription claims for antimalarial drugs (82%) and oral glucocorticoids (84%), 5% had claims for cyclophosphamide, and 46% had claims for other immunosuppressants (including mycophenolate, methotrexate, azathioprine, tacrolimus, and leflunomide).
Prevalence of acute cardiac manifestations
A total of 128 youth (18%) had at least one diagnosis code for an acute cardiac manifestation during the observation period. Valvular insufficiency was the most common cardiac diagnosis, followed by pericardial disease ( Table 2 ). There were no significant differences in the prevalence of cardiac diagnoses by age ( 2 ¼ 0.45, p ¼ 0.50). The median time from the first SLE code to the first cardiac diagnosis code was 15 days (IQR 0, 338).
Echocardiogram utilization
A total of 178 (25%) youth with SLE had a billing code for a transthoracic echocardiogram within the baseline period, including 45% of youth with codes for venous thromboembolism/APS, and 40% of those with renal disease. Median time from the first SLE code to first echocardiogram was one day (IQR -18 to 16 days). Approximately 55% of echocardiograms were performed in an ambulatory setting, while the remainder were performed in a hospital setting. The majority (76%) of echocardiograms were billed by cardiologists, and the remaining were billed primarily by hospitals, internists, and pediatricians. There were no significant temporal trends over time in echocardiogram utilization by calendar year (z statistic ¼ 1.47, p ¼ 0.14).
Factors associated with echocardiogram utilization
On univariable analysis, hospitalization within 30 days of SLE diagnosis was the most strongly associated with echocardiography use (odds ratio (OR) 5.23, 95% confidence interval (CI) (3.58, 7.64)). Owing to collinearity with renal disease, seizure, stroke, and venous thromboembolism, hospitalization was not included in variable selection for multivariable analysis. The results of the final multivariable analysis are show in Table 1 . 
Factors associated with ECG utilization
There were 231 (33%) youth with SLE who had an ECG during the baseline period. CNS disease, hypertension, Hispanic ethnicity, and higher education level were independently associated with ECG use (Table 3) . Unlike echocardiography, geographic region was not associated with ECG use and did not meet criteria for inclusion in the multivariable model (p ¼ 0.5, likelihood ratio test).
Provider characteristics associated with echocardiogram utilization
In the subgroup analysis of youth seen by a rheumatologist during the baseline period, there was a trend toward higher odds of 
Echocardiography use and incident diagnosis of cardiac disease
Among youth imaged during the baseline period, 80 (45%) received their first diagnosis of an acute cardiac manifestation after a median of 0 days (IQR 0-7) following the first echocardiogram. Of the 37 patients who did not undergo echocardiogram during the baseline period but were later diagnosed with cardiac disease, median time from SLE diagnosis to the first cardiac code was 546 days (IQR 287-1313) and valvular insufficiency comprised the majority of diagnoses (Table 2 ).
There was a significant positive correlation between the proportion of youth in each region who had an echocardiogram at baseline and the proportion of imaged youth who received an incident cardiac diagnosis following echocardiography (r ¼ 0.71, p ¼ 0.05). There was no significant correlation between age or non-white race with incident cardiac diagnosis following echocardiography ((r ¼ 0.09, p ¼ 0.21) and r ¼ 0.13, p ¼ 0.09, respectively). Adjustment for patient characteristics using the regional utilization probability index yielded similar results. There was a strong positive correlation between observed over expected probability of echocardiography and the percentage of imaged youth with incident cardiac diagnoses by region (r ¼ 0.78, p ¼ 0.02) (Figure 1 ). Limiting SLE cases to antimalarial users (r ¼ 0.95, p < 0.01) and excluding valvular insufficiency from the outcome (r ¼ 0.67, p ¼ 0.07) did not significantly change the results. Among youth who had echocardiograms, 78% had at least one diagnosis code for a cardiovascular sign or symptom during the baseline period, compared to 38% of youth who did not have an echocardiogram (Table 4) . In both groups, the most commonly coded symptom was chest pain, followed by dyspnea. The type of symptom codes did not differ between those with or without echocardiograms ( 2 ¼ 9.5, p ¼ 0.22). Within 30 days preceding the first echocardiogram, 51% of imaged youth had codes for cardiovascular symptoms. There was no correlation between cardiovascular symptoms within 30 days and incident cardiac diagnosis following echocardiography (r ¼ 0.02, p ¼ 0.75).
Discussion
In this large, population-based study of children and young adults with new-onset SLE, there were several findings regarding acute cardiac disease and early use of echocardiography that may have important clinical implications. First, nearly onefifth of youth had acute cardiac manifestations of SLE, the majority of which occurred near the time of SLE diagnosis. Second, use of echocardiography at SLE diagnosis was highly variable across regions. Third, we observed an increase in the percentage of echocardiograms followed by a new cardiac diagnosis with increasing regional echocardiogram utilization indices. Lastly, preceding codes for cardiovascular symptoms did not correlate with new cardiac diagnoses following echocardiography. Our results point to the need for critical assessment of the incremental diagnostic benefit of echocardiography in youth newly diagnosed with SLE, and for improved risk stratification to determine which youth warrant imaging at diagnosis. We observed up to a five-fold difference across geographic regions in the odds of echocardiography use that was not explained by other patient demographic or disease characteristics. Our results are consistent with previous studies of Medicare beneficiaries, which demonstrate substantial regional variation in the use of echocardiography and other noninvasive diagnostic imaging procedures. 25 To explain variation, the authors recommended considering clinical factors, supply of specialists, and availability of services. 26 As expected, we found positive associations between echocardiography use and markers of disease severity such as renal and CNS involvement, but adjustment for these clinical factors did not explain the geographic variation. Second, we assessed potential practice differences between adult and pediatric rheumatologists since many adult rheumatologists care for children in underserved areas of the US. However, adjusting for provider type also failed to explain regional variability. Third, although patterns of echocardiography use may follow overall health service utilization trends, 26 the geographic variability we observed for echocardiograms did not follow patterns of ECG use. Our results suggest that there may be factors influencing resource allocation and practice variation specific to echocardiography that need to be explored further.
Heuristic approaches, peer practice norms, and differences among individual physicians' assessments of the value of specific tests may all influence use of noninvasive imaging. 27 This may be particularly relevant in pediatric rheumatology, where there are a limited number of providers, and practice norms at single centers may drive service utilization across a large region. Some centers may routinely image all youth at SLE diagnosis, while others selectively image only those suspected of having cardiac involvement. In our study, nearly 40% of youth who did not undergo echocardiography had the same cardiovascular sign and symptom codes as those who did, suggesting there may be differences in physicians' assessment of the value of echocardiography in patients presenting with cardiovascular symptoms, or in clinical factors not able to be assessed by claims data. While heuristic approaches to care are not inherently bad, it is important to consider which deviations reflect decreased quality. Several authors have suggested that unexplained regional variability results from inappropriate use of imaging. 28 In the context of our study, inappropriate use could refer either to underutilization (failure to detect cardiac involvement) or overutilization (provision of echocardiograms that are not necessary for diagnosis of cardiac disease and lead to increased cost or undue worry). As a result, our study highlights the need to study the potential benefit of diagnostic imaging in this population that already incurs significant health-related expenditures.
To generate preliminary data about the potential value of echocardiograms in youth with SLE, we estimated the relationship between early echocardiogram use and identification of cardiac manifestations of lupus. Interestingly, there was a strong positive correlation between higher adjusted regional echocardiogram use and the proportion of imaged youth diagnosed with their first acute cardiac manifestation following echocardiography. Normally in overuse scenarios, further increases in utilization result in little or no incremental diagnostic benefit. In our study we observed that increases in utilization resulted in greater incremental diagnostic benefit. There are several potential explanations for our results. First, the incidence of cardiac disease may simply be higher in regions where utilization is the highest. However, overall severity of SLE is expected to be lower in areas with higher latitude and greater ultraviolet B exposure, where echocardiogram use was highest. 29 Second, providers in regions who request echocardiograms more frequently may be more attuned to identifying or coding cardiac manifestations. Lastly, the low diagnosis rate of cardiac manifestations in low-utilizing regions may reflect underuse of echocardiography. While no definitive conclusions can be made about underuse, we can hypothesize that some of the variation in care may result in under-detection of cardiac disease. Underuse is difficult to estimate, because there is no defined therapeutic effect of imaging and the negative effects on outcomes are indirect. 27 Prospective studies considering the long-terms benefits of early detection and treatment of disease will be needed to define underuse 28 -and perhaps more important, appropriate use-of echocardiography in youth with SLE.
Risk stratification is an important tool to define appropriate use of cardiovascular imaging. 27 Current American Society of Echocardiography guidelines recommend echocardiograms only for adults with SLE who have antiphospholipid antibodies or suggestive signs and symptoms, 5 but there are no guidelines specific to childhood-onset SLE. In our study, only 45% of youth with APS underwent echocardiography, and the presence of cardiovascular symptom codes was not correlated with cardiac diagnoses after echocardiography. This is consistent with numerous studies in adults with SLE demonstrating a high prevalence of asymptomatic cardiac disease. 1, 2, 30 Some authors argue that echocardiography should therefore be performed routinely. [6] [7] [8] In the absence of known risk factors for cardiac involvement, routine echocardiography may be perceived to have a greater impact on childhood-onset disease because of the higher cumulative risk of organ damage. The trend toward increased use of echocardiography among youth seen by pediatric versus adult rheumatologists may partially reflect such provider preferences, in addition to access to pediatric imaging services and patient factors. Understanding the burden and risk factors for cardiac disease in childhood-onset SLE will be a necessary step in determining the utility of screening echocardiograms.
There are several limitations to our study. First, rates of echocardiography in this study may not be generalizable to other health systems with different accessibility and reimbursement schema. However, the degree of variation in imaging use within different health systems has been shown to be similar despite differences in absolute utilization rates. 31 As a result, the geographic variability we observed in our study may be generalizable. A second limitation is that we were not able to assess differences at the level of hospital referral centers. Third, indications for echocardiography cannot be determined using claims data. We examined preceding cardiovascular symptom codes, but future studies with linked medical records or prospective data collection are necessary to corroborate our data. Last, there are limitations of using ICD-9 codes to evaluate disease manifestations. We were unable to quantify the severity of cardiac lesions such as valvular insufficiency, which can be trivial or mild in normal individuals. Valvular insufficiency that is coded by physicians is likely to be greater than trivial; however, the clinical relevance of these diagnoses will need to be confirmed in future echocardiography studies.
To our knowledge, this is the only populationbased study of cardiac manifestations of childhoodonset SLE, and the first study to evaluate the relationship between early noninvasive cardiovascular imaging use and diagnostic outcomes in youth with SLE. Our data suggest there may be incremental diagnostic value to increasing overall utilization of echocardiography, and the next steps are to determine whether screening echocardiography contributes to this increase in diagnostic value. Studies of unselected youth with SLE with and without cardiovascular signs or symptoms would help determine whether there is under-or over-detection of clinically important cardiac disease. There is a need for improved riskstratification strategies to reduce practice variation and critical evaluations of how echocardiography affects subsequent care, patient outcomes, and cost to determine optimal use.
